Logo-bi
Bioimpacts. 2024;14(4): 29957. doi: 10.34172/bi.2023.29957
PMID: 39104623        PMCID: PMC11298019

Review

Cancer treatment comes to age: from one-size-fits-all to next-generation sequencing (NGS) technologies

Sepideh Parvizpour 1,2 * ORCID, Hanieh Beyrampour-Basmenj 2, Jafar Razmara 3 * ORCID, Farhad Farhadi 4, Mohd Shahir Shamsir 5

Cited by CrossRef: 0


1- Karimi S, Bakhshali R, Bolandi S, Zahed Z, Mojtaba Zadeh S, Kaveh Zenjanab M, Jahanban Esfahlan R. For and against tumor microenvironment: Nanoparticle-based strategies for active cancer therapy. Materials Today Bio. 2025;31:101626 [Crossref]
2- Hassan B, Elagamy S. Personalized medical recommendation system with machine learning. Neural Comput & Applic. 2025;37(9):6431 [Crossref]
3- Wang H, Huang J, Fang X, Liu M, Fan X, Li Y. Advances in next-generation sequencing (NGS) applications in drug discovery and development. Expert Opinion on Drug Discovery. 2025;20(4):537 [Crossref]


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMedPubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science IndicatorsEmbase; EBSCOhost; CAS: DOAJSHERPA/RoMEO
Member of COPE
Follower of ICMJE
Permission: Creative Commons